UPS to Invest $48M in 27 Temperature-Controlled Facilities for GLP-1 Weight-Loss Drugs
UPS announced a $48 million investment to build 27 temperature-controlled facilities specifically designed to handle the shipping of medications that require refrigeration, including GLP-1 weight-loss drugs. The move is driven by rapidly growing demand for such pharmaceuticals. The new infrastructure will ensure proper cold-chain conditions for sensitive medicines.
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!